Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

Tagged cbm review · clear

Eligibility for CBM Review Is Not Appealable

SIPCO, LLC v. EMERSON ELECTRIC CO. Before O’Malley, Reyna, and Chen. Appeal from the Patent Trial and Appeal Board. Summary: The Board’s determination that a patent qualifies for CBM review is non-appealable under 35 U.S.C. § 324(e).…

November 18, 2020PTAB2 min read

Federal Circuit Affirms Patent-Ineligibility of Claims Directed to Displaying Financial Information on a Known Device

Before Moore , Clevenger, and Wallach. Appeal from the Patent Trial and Appeal Board. Summary : Claims directed to providing additional trading information on a prior art display, without more, are patent-ineligible under 35 U.S.C. § 101. IBG and…

May 1, 2019PTAB1 min read